Atlas Trials

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Clinical trial NCT06080789 · RECRUITING

Trial details

NCT number
NCT06080789
Sponsor
Panafina, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Pancreatitis
Start date
2024-06-28
Primary completion
2026-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.